Company Name
CISEN PHARMACEUTICAL CO.,LTD.
Year of Establishment
1970
Enterprise Size
more than 1000
Annual Turnover(USD)
500,000 to 99,999,999
Company Introduction
Cisen Pharma is an integrated chemical pharmaceutical Co.,Ltd., which was founded on 1970 and listed on main board of SGX 2017. Our products cover the seven following dosage form: LVP\SVP\OSD\Lyophilized PFI(Including PFI)\External Use Product\API\ FSMP(Food for Special Medical Purpose). The following eight therapuetic area: Parenteral Nutrition, Antineoplastic, CVD, Digestive system, Diabetes, Respiratory System, Anesthesia and its aid, Anti-depression are included. External use product, such as eye drop, ointment, cream, aseptic eye ointment;API: Heparin Sodium;Enoxaparin Sodium;Dexmedetomidine HCL and so on.
Main Competitive Advantages
Brand Name,International Approvals/Standards,Experienced R&D Staff,Delivery Term,Production Capacity,Large Product Line,Contract Manufacturing (CRO,CMO),Buyers' Specifications Accepted,Small Orders Accepted,Reputation,Quality Service,
Website
http://www.cisen-pharma.com
Other Competitive Advantages
Cisen Pharma, which can covers from the API to FP, the whole industry chain, can meet your one-stop purchase requirement.
Patents and Copyright
N.A.
Milestone
Founded in 1970
Listed on the main board of the Shanghai Stock Exchange on 2017
CISENPHARMACEUTICAL COMPANY INDIA PRIVATE LIMITED,which was in charge of R&D, on 2018
Passed CGMP audit from US FDA on 2019
Esomeprazole Magnesium Delayed Release Capsule was approved by US FDA on 2021